⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 25, 2003Blood

Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets

View Full Paper

Ask AI

Bookmark

Share

Authors

LMLaurent O. MosnierScripps Research Institute PBPaula BuijtenhuijsUtrecht University PMPauline F. MarxAmsterdam University Medical Centers

Discussion

Loading...

Member takes

Implication

Platelet TAFI secretion may modulate local fibrinolysis; leaves open its role in thrombosis and need for clinical studies.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mosnier et al. (2003) studied this question.

synapsesocial.com/papers/6a80acf1ea50fa4f0792a155 https://doi.org/10.1182/blood-2002-09-2944

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis2000 · 375 citations
2Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled2001 · 144 citations
3Characterization of a new megakaryocytic cell line: the Dami cell1988 · 278 citations
4In vitro establishment and characterization of a human megakaryoblastic cell line1990 · 131 citations
5Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms1994 · 136 citations